FDA Microbiology Devices Panel Advisory Committee: HPV Diagnostics
A public advisory committee meeting of the FDA’s Microbiology Devices Panel be held on March 8, 2019 in Gaithersburg, Maryland. The committee will discuss and make recommendations regarding new or alternative approaches to the clinical study design and evaluation of devices detecting Human Papillomavirus (HPV) nucleic acid. Topics to be addressed at the meeting include
